MedPath

Post Prandial Individual Responses to Different Foods

Not Applicable
Not yet recruiting
Conditions
PreDiabetes
Diabetes Mellitus, Type 2
Healthy
Registration Number
NCT06989164
Lead Sponsor
Stanford University
Brief Summary

This study aims to understand why people respond differently to the same foods, especially when it comes to changes in blood sugar after eating. A continuous glucose monitors (CGMs) will be used to observe how individuals respond to specific meals and drinks (e.g., Oral Glucose Tolerance Test, OGTT). By studying these patterns, the investigators hope to identify different types of metabolism and see if certain foods or food ingredients (like fiber, amino acids, or vinegar) can help control blood sugar better for specific groups. This research will help lay the groundwork for personalized dietary advice based on a person's unique biology.

Detailed Description

Participants in the study will be provided with a continuous glucose monitor (CGM) and pre-measured cooked rice to test with different potential mitigators: fiber, acid, amino acid (e.g., leucine), whole protein, and exercise. Each of these conditions will be tested on a different day following strict instructions. For some of these tests, participants will be asked to collect a blood microsample and a saliva sample before and after eating the test meal. A stool sample will be collected at baseline.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
100
Inclusion Criteria
  • BMI (body mass index) >19 kg/m2 but < 45 kg/m2
  • HbA1c < or equal to 7.0% while not on antihyperglycemic medications
  • Be willing to provide written informed consent for all study procedures.
  • Able to commute to Stanford campus for on-site visits
Exclusion Criteria
  • recent (<6mos) CVD (cardiovascular disease) event
  • active malignancy
  • kidney/liver disease
  • pregnancy/lactation
  • chronic inflammatory disease
  • eating disorder
  • bariatric surgery
  • history of acute pancreatitis
  • current use of antihyperglycemic, diabetogenic, or weight loss medications
  • heavy alcohol use
  • physical activity >2 hours/day
  • inability to come to Stanford CTRU (Clinical and Translational Research Unit) for metabolic testing

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Post prandial peak glucose levels3 hours

Delta glucose peak within 3 hours after consuming the standard meal - peak glucose value minus baseline glucose value at time 0 measured by CGM in mg/dL.

Post prandial glucose area under the curve (AUC)3 hours

AUC (\>baseline) within three hours measured by CGM in mg/dL during the 3 hours after each study meal.

Secondary Outcome Measures
NameTimeMethod
Glucose time to peak3 hours

The time in minutes from baseline to peak within 3 hours measured by CGM after each standardized meal.

Changes in personal post prandial metabolic states as measured in micro-sampling by targeted and untargeted metabolomics (LC-MS)1 hour

Dry blood samples will be collected by micro-sampling before and 1 hour after the standardized meals. Based on those samples, metabolomics (e.g., short-chain fatty acids, amino acids and other polar and nonpolar metabolites) will be extracted and quantified by liquid chromatography mass spectrometry (LC-MS). Both hydrophilic LC and reverse phase LC will be used. Q Exactive will be used for MS. Tandem MS will be collected for annotation. Relative quantification will be used, where the level of metabolites can be compared between samples. Chemical reference will be used for the absolute quantification of targeted metabolites.

Individual microbiome compositionBaseline

Microbiome will be defined by using metagenomics assay to baseline samples

Changes in postprandial proteomic responses as measured in micro-sampling by Olink1 hour

Dry blood samples will be collected by micro-sampling frequently before and after the standardized meals. Based on those samples, proteomics will be quantified by proximity extension assay for the cardiometabolic panel. 96 proteins will be measured in the unit of normalized protein expression.

Trial Locations

Locations (1)

Stanford University

🇺🇸

Stanford, California, United States

Stanford University
🇺🇸Stanford, California, United States
© Copyright 2025. All Rights Reserved by MedPath